REGISTERED
on 25 Jan 2022
Last Applicant/ Owned by
1801 AUGUSTINE CUT-OFF
WILMINGTON
DE
19803
Serial Number
90261228 filed on 17th Oct 2020
Registration Number
6625338 registered on 25th Jan 2022
Correspondent Address
Frances M. Jagla
Filing Basis
1. intent to use
Disclaimer
NO DATA
MINJUVI
Research and development in the pharmaceutical and biotechnology fields; research and development of medicines; scientific and technological services and research and design services, namely, scientific research, analysis, and testing services in the fields of analytical chemistry, biochemistry, medicinal chemistry, drug development, biotechnology, microbiology and molecular biology; biological re Read More
Classification Information
Class [042]
Computer & Software Services & Scientific Services
Research and development in the pharmaceutical and biotechnology fields; research and development of medicines; scientific and technological services and research and design services, namely, scientific research, analysis, and testing services in the fields of analytical chemistry, biochemistry, medicinal chemistry, drug development, biotechnology, microbiology and molecular biology; biological research, clinical research in the field of antibodies and pharmaceuticals, and medical research; chemical and biochemical analysis services; laboratory research in the fields of analytical chemistry, biochemistry, medicinal chemistry, drug development, biotechnology, microbiology and molecular biology; clinical research in connection with the treatment and prevention of metabolic disorders, infectious diseases, cancer, inflammatory diseases, Alzheimer, sepsis, and restenosis; conducting clinical trials for others; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Research and development services in the field of antibodies
First Use Date in General
N/A
First Use Date in Commerce
N/A
Class [005]
Pharmaceutical Products
Pharmaceuticals and pharmaceutical preparations for human use for the treatment and prevention of metabolic disorders, infectious diseases, cancer, inflammatory diseases, Alzheimer, sepsis, and restenosis; biological preparations in the nature of antibodies for use in the treatment of metabolic disorders, infectious diseases, cancer, inflammatory diseases, Alzheimer, sepsis, and restenosis; antibodies sold as a component ingredient of pharmaceuticals for the treatment of metabolic disorders, infectious diseases, cancer, inflammatory diseases, Alzheimer, sepsis, and restenosis; antibodies for use in the manufacture of active ingredients of pharmaceuticals and vaccines; diagnostic preparations for medical purposes; biological substances for human medical diagnostics and analysis for the treatment of metabolic disorders, infectious diseases, cancer, inflammatory diseases, Alzheimer, sepsis, and restenosis; sanitary preparations for medical use; medical diagnostic reagents; clinical medical reagents; Biological preparations for medical purposes for the treatment of metabolic disorders, infectious diseases, cancer, inflammatory diseases, Alzheimer, sepsis, and restenosis
First Use Date in General
N/A
First Use Date in Commerce
N/A
Mark Details
Serial Number
No 90261228
Mark Type
No Service Mark
Attorney Docket Number
No 2854-T339US
44D Filed
Yes
44D Current
No
44E filed
Yes
44E Current
Yes
66A Filed
No
66A Current
No
Current Basis
No
No Basis
No
Legal History
| Status Date | Action Taken |
|---|---|
| 17th Jun 2024 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| 17th Jun 2024 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| 17th Jun 2024 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| 17th Jun 2024 | TEAS CHANGE OF OWNER ADDRESS RECEIVED |
| 17th Jun 2024 | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |
| 31st Jan 2024 | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP |
| 25th Jan 2022 | REGISTERED-PRINCIPAL REGISTER |
| 09th Nov 2021 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| 09th Nov 2021 | PUBLISHED FOR OPPOSITION |
| 20th Oct 2021 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |